Interim Results for Iluzanebart (VGL101) From IGNITE, the First Interventional Phase 2 Study in Patients With ALSP

VGL-101 - Vigil Neuro

Seala (VG101) - Bionovo

D. Lynch 1; J. Gelfand 2; R. Kumar 3; D. McLaren 4; A. Meier 4; R. Rajagovindan 4; Z. Wszolek 5

Jul 2, 2024